Axol Bioscience
Cambridge
About Axol Bioscience
Axol specialize in human cell culture. Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. These are iPSC-derived cells and the media and reagents required to successfully culture these cells. The company also do iPSC reprogramming and differentiation to various cell types as a service for customers that wish to use their own patient-derived samples. Axol is headquartered and maintains production on the Chesterford Research Park, a location renowned for inspiring innovation and success, located in Cambridge, UK.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $17.0M
- Last round: Series Unknown (Jan 2026)
- Website: axolbio.com
- Phone: 441223496069
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/axol-bioscience-118362 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.